Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1984 Jan;17(1):77–81. doi: 10.1111/j.1365-2125.1984.tb05002.x

Factors affecting the response to inhibition of drug metabolism by cimetidine--dose response and sensitivity of elderly and induced subjects.

J Feely, L Pereira, E Guy, N Hockings
PMCID: PMC1463297  PMID: 6691891

Abstract

The effect of cimetidine on oxidative drug metabolism was characterised using antipyrine clearance in a group of healthy volunteers. In six subjects cimetidine produced a dose dependent reduction of antipyrine clearance: 400 mg/day (16.8 +/- 2.2%, mean +/- s.e. mean), 800 mg/day (26.3 +/- 1.5%) and 1600 mg/day (33.5 +/- 2.4%). The effect of cimetidine (800 mg/day) was of similar magnitude (approximately 25%) in two groups of six young (21-26 years) and six elderly (65-78 years) subjects. The effect of pretreatment begun just 1 h before administration of antipyrine was similar to that of 24 h pretreatment and that reported for chronic cimetidine pretreatment. The percentage reduction in antipyrine clearance produced by cimetidine 800 mg/day was greater (44 +/- 5 vs 24 +/- 3%; P less than 0.05) in six subjects who had been pretreated with the hepatic enzyme inducer rifampicin (600 mg/day for 21 days) than in the control uninduced state. Although cimetidine was capable of rapidly reversing the effect of rifampicin on antipyrine clearance, following withdrawal of both rifampicin and cimetidine there was still evidence of enzyme induction. These results suggest that the effect of cimetidine on oxidative metabolism is dose dependent, is more marked in enzyme induced subjects, is independent of the duration of pretreatment and is of similar magnitude in young and elderly subjects.

Full text

PDF
77

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Desmond P. V., Patwardhan R., Parker R., Schenker S., Speeg K. V., Jr Effect of cimetidine and other antihistaminics on the elimination of aminopyrine, phenacetin and caffeine. Life Sci. 1980 Apr 14;26(15):1261–1268. doi: 10.1016/0024-3205(80)90071-5. [DOI] [PubMed] [Google Scholar]
  2. Drayer D. E., Romankiewicz J., Lorenzo B., Reidenberg M. M. Age and renal clearance of cimetidine. Clin Pharmacol Ther. 1982 Jan;31(1):45–50. doi: 10.1038/clpt.1982.7. [DOI] [PubMed] [Google Scholar]
  3. Feely J., Wilkinson G. R., Wood A. J. Reduction of liver blood flow and propranolol metabolism by cimetidine. N Engl J Med. 1981 Mar 19;304(12):692–695. doi: 10.1056/NEJM198103193041202. [DOI] [PubMed] [Google Scholar]
  4. Feely J., Wormsley K. G. New drugs. H2 receptor antagonists--cimetidine and ranitidine. Br Med J (Clin Res Ed) 1983 Feb 26;286(6366):695–697. doi: 10.1136/bmj.286.6366.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Klotz U., Reimann I. Delayed clearance of diazepam due to cimetidine. N Engl J Med. 1980 May 1;302(18):1012–1014. doi: 10.1056/NEJM198005013021807. [DOI] [PubMed] [Google Scholar]
  6. May D. C., Jarboe C. H., VanBakel A. B., Williams W. M. Effects of cimetidine on caffeine disposition in smokers and nonsmokers. Clin Pharmacol Ther. 1982 May;31(5):656–661. doi: 10.1038/clpt.1982.91. [DOI] [PubMed] [Google Scholar]
  7. Patwardhan R. V., Johnson R. F., Sinclair A. P., Schenker S., Speeg K. V., Jr Lack of tolerance and rapid recovery of cimetidine-inhibited chlordiazepoxide (Librium) elimination. Gastroenterology. 1981 Sep;81(3):547–551. [PubMed] [Google Scholar]
  8. Prescott L. F., Adjepon-Yamoah K. K., Roberts E. Rapid gas-liquid chromatographic estimation of antipyrine in plasma. J Pharm Pharmacol. 1973 Mar;25(3):205–207. doi: 10.1111/j.2042-7158.1973.tb10625.x. [DOI] [PubMed] [Google Scholar]
  9. Puurunen J., Sotaniemi E., Pelkonen O. Effect of cimetidine on microsomal drug metabolism in man. Eur J Clin Pharmacol. 1980 Aug;18(2):185–187. doi: 10.1007/BF00561588. [DOI] [PubMed] [Google Scholar]
  10. Reilly P. E., Carrington L. E., Winzor D. J. The interaction of cimetidine with rat liver microsomes. Biochem Pharmacol. 1983 Mar 1;32(5):831–835. doi: 10.1016/0006-2952(83)90584-1. [DOI] [PubMed] [Google Scholar]
  11. Rendić S., Kajfez F., Ruf H. H. Characterization of cimetidine, ranitidine, and related structures' interaction with cytochrome P-450. Drug Metab Dispos. 1983 Mar-Apr;11(2):137–142. [PubMed] [Google Scholar]
  12. Rendić S., Sunjić V., Toso R., Kajfez F., Ruf H. H. Interaction of cimetidine with liver microsomes. Xenobiotica. 1979 Sep;9(9):555–564. doi: 10.3109/00498257909042321. [DOI] [PubMed] [Google Scholar]
  13. Roberts R. K., Grice J., Wood L., Petroff V., McGuffie C. Cimetidine impairs the elimination of theophylline and antipyrine. Gastroenterology. 1981 Jul;81(1):19–21. [PubMed] [Google Scholar]
  14. Salem S. A., Rajjayabun P., Shepherd A. M., Stevenson I. H. Reduced induction of drug metabolism in the elderly. Age Ageing. 1978 May;7(2):68–73. doi: 10.1093/ageing/7.2.68. [DOI] [PubMed] [Google Scholar]
  15. Serlin M. J., Sibeon R. G., Mossman S., Breckenridge A. M., Williams J. R., Atwood J. L., Willoughby J. M. Cimetidine: interaction with oral anticoagulants in man. Lancet. 1979 Aug 18;2(8138):317–319. doi: 10.1016/s0140-6736(79)90340-4. [DOI] [PubMed] [Google Scholar]
  16. Somogyi A., Gugler R. Drug interactions with cimetidine. Clin Pharmacokinet. 1982 Jan-Feb;7(1):23–41. doi: 10.2165/00003088-198207010-00002. [DOI] [PubMed] [Google Scholar]
  17. Somogyi A., Rohner H. G., Gugler R. Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients. Clin Pharmacokinet. 1980 Jan-Feb;5(1):84–94. doi: 10.2165/00003088-198005010-00003. [DOI] [PubMed] [Google Scholar]
  18. Speeg K. V., Jr, Patwardhan R. V., Avant G. R., Mitchell M. C., Schenker S. Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents. Gastroenterology. 1982 Jan;82(1):89–96. [PubMed] [Google Scholar]
  19. Vesell E. S. The antipyrine test in clinical pharmacology: conceptions and misconceptions. Clin Pharmacol Ther. 1979 Sep;26(3):275–286. doi: 10.1002/cpt1979263275. [DOI] [PubMed] [Google Scholar]
  20. Vestal R. E., Thummel K. E., Musser B., Mercer G. D. Cimetidine inhibits theophylline clearance in patients with chronic obstructive pulmonary disease: a study using stable isotope methodology during multiple oral dose administration. Br J Clin Pharmacol. 1983 Apr;15(4):411–418. doi: 10.1111/j.1365-2125.1983.tb01523.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wood A. J., Vestal R. E., Wilkinson G. R., Branch R. A., Shand D. G. Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination. Clin Pharmacol Ther. 1979 Jul;26(1):16–20. doi: 10.1002/cpt197926116. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES